Jankistomig

N/A

Report date: 2024/11/15 17:30:57

Base Information

Drug NameJankistomig

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsProgrammed cell death protein 1 blockers

TargetsVascular endothelial growth factor receptor 2Programmed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOttimo Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesOttimo Pharma Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A